News & Publications

The Newsroom

April 4, 2024

Algen to present at the inaugural J.P. Morgan Asset Management: Life Sciences Innovation Summit 2024

Press
Arrow
January 8, 2024

CEO and Co-Founder Chun-Hao Huang presents at Biotech Showcase 2024 during JPM week

Press
Arrow
September 27, 2023

Algen presents innovation in using CRISPR/AI to uncover disease-driving RNA messages for therapeutics discovery at Discovery on Target 2023

Press
Arrow
June 7, 2023

Algen unveils AlgenBrain platform at BIO International Convention 2023

Press
Arrow
August 31, 2021

Algen debuts at Y Combinator’s Summer 2021 Demo Day

Press
Arrow
October 17, 2018

Illumina Accelerator announces eighth investment cycle

Press
Arrow

Publications

AlgenBrain: reverse-engineering disease trajectories with CRISPR and AI
View publication
Arrow
Biopharma Dealmakers - Nature Portfolio
A preclinical platform for assessing antitumor effects and systemic toxicities of cancer drug targets
View publication
Arrow
PNAS
Applications of CRISPR-Cas Enzymes in Cancer Therapeutics and Detection
View publication
Arrow
Trends in Cancer - Cell Press
p53 Represses the Mevalonate Pathway to Mediate Tumor Suppression
View publication
Arrow
Cell

Work with us

We are on a groundbreaking journey to redefine possibilities in biology

AlgenBio Jobs
AboutTeamAdvisors
ApproachPlatformPipeline
News & PublicationsNewsPublications
Top Arrow
2025 Algen Biotechnologies – All Rights Reserved

Contact Us

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.